June 01, 2023 / 12:12 IST
Reported Consolidated quarterly numbers for ANG Lifesciences India are:Net Sales at Rs 39.44 crore in March 2023 down 58.65% from Rs. 95.38 crore in March 2022.
Story continues below Advertisement
Quarterly Net Loss at Rs. 4.61 crore in March 2023 down 187.77% from Rs. 5.25 crore in March 2022.
EBITDA stands negative at Rs. 1.04 crore in March 2023 down 107.81% from Rs. 13.31 crore in March 2022.
ANG Lifescience shares closed at 69.80 on May 31, 2023 (BSE) and has given -47.72% returns over the last 6 months and -64.02% over the last 12 months.
| ANG Lifesciences India | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Mar'23 | Dec'22 | Mar'22 | | Net Sales/Income from operations | 39.44 | 46.93 | 95.38 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 39.44 | 46.93 | 95.38 | | EXPENDITURE | | Consumption of Raw Materials | 38.71 | 32.81 | 68.01 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -2.00 | -2.76 | -0.86 | | Power & Fuel | -- | -- | -- | | Employees Cost | 5.85 | 5.36 | 5.76 | | Depreciation | 3.03 | 2.13 | 2.61 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 7.16 | 8.76 | 9.73 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -13.31 | 0.63 | 10.13 | | Other Income | 9.23 | 0.24 | 0.57 | | P/L Before Int., Excpt. Items & Tax | -4.07 | 0.87 | 10.70 | | Interest | 1.65 | 3.47 | 3.92 | | P/L Before Exceptional Items & Tax | -5.73 | -2.60 | 6.78 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -5.73 | -2.60 | 6.78 | | Tax | -1.12 | -0.83 | 1.53 | | P/L After Tax from Ordinary Activities | -4.61 | -1.78 | 5.25 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -4.61 | -1.78 | 5.25 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -4.61 | -1.78 | 5.25 | | Equity Share Capital | 13.06 | 13.06 | 10.37 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -3.63 | -1.36 | 5.16 | | Diluted EPS | -3.63 | -1.36 | 5.16 | | EPS After Extra Ordinary | | Basic EPS | -3.63 | -1.36 | 5.16 | | Diluted EPS | -3.63 | -1.36 | 5.16 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
